No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis

被引:10
作者
Fiebeler, A
Borgmann, S
Woywodt, A
Haller, H
Haubitz, M [1 ]
机构
[1] Hannover Med Sch, Dept Nephrol, Div Nephrol, HELIOS, D-30623 Hannover, Germany
[2] Franz Volhard Clin, Div Nephrol, Berlin, Germany
[3] Univ Tubingen, Div Med Microbiol, Tubingen, Germany
关键词
ANCA; microscopic polyangiitis; myeloperoxidase; polymorphism; vasculitis; Wegener's granulomatosis;
D O I
10.1093/ndt/gfh025
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. The activation of neutrophils and monocytes by ANCA, resulting in the release of reactive oxygen species and proteases like myeloperoxidase (MPO),. is essential to the pathogenesis of ANCA-associated vasculitis. As the A allele of the G-463A MPO gene polymorphism is associated with diminished activity of MPO, it is conceivable that the presence of this allele protects against MPO-ANCA-associated vasculitis. Methods. Allelic frequencies of the G-463A polymorphism were studied in 119 ANCA-associated vasculitis patients, 48 with MPO-ANCA and 71 with proteinase 3 (PR3)-ANCA. Results. Allelic frequencies of MPO G-463A promoter polymorphism did not differ between MPO-ANCA and PR3-ANCA-associated vasculitis patients. Moreover, allelic distribution was similar to that of the normal population. Conclusions. The data suggest that G-463A polymorphism does not seem to contribute to either MPO-ANCA- or PR3-ANCA-associated vasculitis formation.
引用
收藏
页码:969 / 971
页数:3
相关论文
共 13 条
[1]  
Cascorbi I, 2000, CANCER RES, V60, P644
[2]   ANTIBODIES AGAINST GRANULE PROTEINS ACTIVATE NEUTROPHILS INVITRO [J].
CHARLES, LA ;
CALDAS, MLR ;
FALK, RJ ;
TERRELL, RS ;
JENNETTE, JC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (06) :539-546
[3]   Proteinase 3 gene polymorphisms and Wegener's granulomatosis [J].
Gencik, M ;
Meller, S ;
Borgmann, S ;
Fricke, H .
KIDNEY INTERNATIONAL, 2000, 58 (06) :2473-2477
[4]   Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis [J].
Hagen, EC ;
Daha, MR ;
Hermans, J ;
Andrassy, K ;
Csernok, E ;
Gaskin, G ;
Lesavre, P ;
Lüdemann, J ;
Rasmussen, N ;
Sinico, RA ;
Wiik, A ;
van der Woude, FJ .
KIDNEY INTERNATIONAL, 1998, 53 (03) :743-753
[5]  
Kallenberg CGM, 2002, CLEV CLIN J MED, V69, P61
[6]   Autoantibodies to myeloperoxidase: clinical and pathophysiological significance [J].
Kallenberg, CGM .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (10) :682-687
[7]  
London SJ, 1997, CANCER RES, V57, P5001
[8]   Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis [J].
Rarok, AA ;
Stegeman, CA ;
Limburg, PC ;
Kallenberg, CGM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09) :2232-2238
[9]  
Reumaux Dominique, 2000, Clinical and Experimental Immunology, V120, P40
[10]   -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis [J].
Reynolds, WF ;
Stegeman, CA ;
Tervaert, JWC .
CLINICAL IMMUNOLOGY, 2002, 103 (02) :154-160